Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-08T23:38:22.297Z Has data issue: false hasContentIssue false

Forecasting the epidemiological trends of COVID-19 prevalence and mortality using the advanced α-Sutte Indicator

Published online by Cambridge University Press:  05 October 2020

Yongbin Wang*
Affiliation:
Department of Epidemiology and Health Statistics, School of Public Health, Xinxiang Medical University, Xinxiang, Henan Province, P.R. China
Chunjie Xu
Affiliation:
Department of Occupational and Environmental Health, School of Public Health, Capital Medical University, Beijing, P.R. China
Sanqiao Yao
Affiliation:
Department of Epidemiology and Health Statistics, School of Public Health, Xinxiang Medical University, Xinxiang, Henan Province, P.R. China
Yingzheng Zhao
Affiliation:
Department of Epidemiology and Health Statistics, School of Public Health, Xinxiang Medical University, Xinxiang, Henan Province, P.R. China
*
Author for correspondence: Yongbin Wang, E-mail: wybwho@163.com
Rights & Permissions [Opens in a new window]

Abstract

Forecasting the epidemics of the diseases is very valuable in planning and supplying resources effectively. This study aims to estimate the epidemiological trends of the coronavirus disease 2019 (COVID-19) prevalence and mortality using the advanced α-Sutte Indicator, and its prediction accuracy level was compared with the most frequently adopted autoregressive integrated moving average (ARIMA) method. Time-series analysis was performed based on the total confirmed cases and deaths of COVID-19 in the world, Brazil, Peru, Canada and Chile between 27 February 2020 and 30 June 2020. By comparing the prediction reliability indices, including the root mean square error, mean absolute error, mean error rate, mean absolute percentage error and root mean square percentage error, the α-Sutte Indicator was found to produce lower forecasting error rates than the ARIMA model in all data apart from the prevalence testing set globally. The α-Sutte Indicator can be recommended as a useful tool to nowcast and forecast the COVID-19 prevalence and mortality of these regions except for the prevalence around the globe in the near future, which will help policymakers to plan and prepare health resources effectively. Also, the findings of our study may have managerial implications for the outbreak in other countries.

Keywords

Information

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press
Figure 0

Fig. 1. Time series plots displaying the prevalence and mortality cases of COVID-19. (a) The total confirmed cases and deaths worldwide;(b) The total confirmed cases in Brazil, Peru, Canada, and Chile; (c) The total deaths in Brazil, Peru, Canada, and Chile. Worth noting that manycountries, areas or territories recently reconciliated the reported prevalence and mortality data of the COVID-19 outbreak, and thus the prevalenceand mortality data used to build the ARIMA and α-Sutte Indicator models were retrospectively updated on the basis of the additional detailsprovided by WHO, so that we can develop a reliable model for estimating the epidemiological trends of the prevalence and mortality of the COVID-19 outbreak in the upcoming days or weeks.

Figure 1

Fig. 2. Time series plots displaying the resulting forecasts for the testing sets of COVID-19 prevalence and mortality in the five regions using the α-Sutte Indicator and ARIMA models. (a) The resulting forecasts for the testing sets of the COVID-19 prevalence and mortality globally; (b) The resulting forecasts for the testing sets of the COVID-19 prevalence and mortality in Brazil; (c) The resulting forecasts for the testing sets of the COVID-19 prevalence and mortality in Peru; (d) The resulting forecasts for the testing sets of the COVID-19 prevalence and mortality in Canada; (e) The resulting forecasts for the testing sets of the COVID-19 prevalence and mortality in Chile. Here the forecasts for testing data are plotted as gray shaded area. As seen above, it seemed that the forecasts for the testing sets of both the prevalence and mortality from the α-Sutte Indicator yielded more sufficient prediction accuracy compared with that from the ARIMA model in the five regions except for the result from the testing sets of the COVID-19 prevalence around the globe.

Figure 2

Table 1. The identified best ARIMA models to forecast the epidemiological trend of COVID-19 prevalence in the five regions

Figure 3

Table 2. The identified best ARIMA models to forecast the epidemiological trend of COVID-19 mortality in the five regions

Figure 4

Table 3. Comparison of accuracy levels measurement of forecasting for the COVID-19 prevalence and mortality between α-Sutte indicator and ARIMA methods in the five regions

Supplementary material: File

Wang et al. Supplementary Materials

Wang et al. Supplementary Materials

Download Wang et al. Supplementary Materials(File)
File 2.1 MB